Avecia Biotechnology
Avecia developing methods for making adult stem cells for wound healing
Published in Medicine and Law Weekly, May 26th, 2006
The work involves creating cost-effective and scaleable methods for making ethically-derived adult stem cells for therapeutic use, notably for wound healing.
The project aims to bring significant advances in the development of new, fully functional skin tissue to treat burns victims.
Partners in the near-UKP 1 million, 3-year project include the Centre for Stem Cell Discovery & Regenerative Medicine of the U.K.'s Durham University; the Blond McIndoe Centre, prominent in plastic and reconstructive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Business Update
BioScrip named national vendor for Medicare Part B - Business Update
Claimsnet announces contract with Medicare healthcare plan - Chinese Academy of Medical Sciences
Researchers from the People's Republic of China, Israel and Spain describe findings in cancer treatment studies - Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics' Andara product regenerates nerves in chronic spinal cord injury model - CytoCore, Inc.
CytoCore announces hiring of vice president of legal and regulatory affairs - DNAPrint Genomics, Inc.
DNAPrint Genomics receives notice of allowance for patent for identifying genetic links - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
